clevidipine has been researched along with cifenline in 2 studies
| Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (cifenline) | Trials (cifenline) | Recent Studies (post-2010) (cifenline) |
|---|---|---|---|---|---|
| 127 | 19 | 62 | 303 | 49 | 33 |
| Protein | Taxonomy | clevidipine (IC50) | cifenline (IC50) |
|---|---|---|---|
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | 7.8 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.8 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | 7.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
2 other study(ies) available for clevidipine and cifenline
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |